CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
CTIC
Delisted
CTIC was delisted on the 23rd of June, 2023.
63 hedge funds and large institutions have $118M invested in CTI BioPharma Corp. (DE) Common Stock in 2021 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 17 increasing their positions, 16 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
63
Holders Change
+7
Holders Change %
+12.5%
% of All Funds
0.97%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
19
Increased
17
Reduced
16
Closed
11
Calls
$1.07M
Puts
$570K
Net Calls
+$502K
Net Calls Change
+$646K
Top Buyers
| 1 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
$3.68M |
| 2 |
CC
Caxton Corporation
Princeton,
New Jersey
|
$5.55M |
| 3 |
LPC
Lion Point Capital
New York
|
$3.03M |
| 4 |
BlackRock
New York
|
$4.46M |
| 5 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
$21.8M |
Top Sellers
| 1 |
O
OrbiMed
New York
|
$0 |
| 2 |
SI
Sofinnova Investments
Menlo Park,
California
|
$0 |
| 3 |
ACM
Altium Capital Management
New York
|
$5.42M |
| 4 |
Two Sigma Investments
New York
|
$878K |
| 5 |
Two Sigma Advisers
New York
|
$1.38M |
